You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for Patent: 5,034,230


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,034,230
Title: Anti-allergic ophthalmics
Abstract:This invention relates to low irritative ophthalmics containing the compound of the formula or salts thereof which are useful for treatment of anti-allergic eye diseases such as allergic conjunctivitis ##STR1##
Inventor(s): Morita; Takakazu (Toyonaka, JP), Iso; Tadashi (Kawachinagano, JP), Kawashima; Youichi (Kyoto, JP), Hikida; Mitsushi (Takatsuki, JP)
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:07/392,922
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 5,034,230

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,034,230

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-331025Dec 25, 1987
PCT Information
PCT FiledDecember 23, 1988PCT Application Number:PCT/JP88/01296
PCT Publication Date:July 13, 1989PCT Publication Number: WO89/06130

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.